Italia markets closed
  • Reuters

    Relief Therapeutics sees 60-70% chance of COVID-19 drug approval

    Relief Therapeutics' chairman said he was optimistic its RLF-100 (aviptadil) drug will win approval for treating COVID-19 patients in a matter of months. The Swiss group owns the rights to the drug in the United States and Europe. Its U.S. partner NeuroRx is running multicentre clinical trials https://relieftherapeutics.com/clinical-trials-2, including a Phase IIb/III trial in patients who are severely ill because of the consequences of COVID-19, the respiratory disease caused by the new coronavirus.

  • Thomson Reuters StreetEvents

    Edited Transcript of ALV.N earnings conference call or presentation 17-Jul-20 12:00pm GMT

    Q2 2020 Autoliv Inc Earnings Call

  • Reuters

    Hong Kong markets watchdog says it does not think sanctions will affect financial firms

    Hong Kong's markets watchdog is not aware of any aspect of U.S. sanctions imposed on Hong Kong officials that will affect how financial firms carry on their normal operations in the city, a spokesman said on Saturday. The United States on Friday imposed sanctions on Hong Kong Chief Executive Carrie Lam, the territory's current and former police chiefs and eight other top officials for what Washington says is their role in curtailing political freedoms in the territory. "Many global firms have prior experience of properly assessing and responding to specific U.S. sanctions to the extent they may affect any of their clients and related activities," the spokesman for the markets watchdog said.

Usando Yahoo accetti che Yahoo e i suoi partners utilizzino cookies per fini di personalizzazione e altre finalità